Dr. Julie Zimbelman is a pediatric hematologist oncologist with the Rocky Mountain Pediatric Hematology Oncology Clinic. She attended medical school at the University of Colorado School of Medicine in Denver. Dr. Zimbelman completed her pediatric residency as well as her pediatric hematology-oncology and bone marrow transplant fellowship at University of Colorado Health Sciences Center. Dr. Zimbelman is an active member of the Denver Clinic involved in the treatment of childhood osteosarcoma.

CURRICULUM VITAE
Julie D. Zimbelman, M.D.
Pediatric Hematologist-Oncologist
Rocky Mountain Pediatric Hematology Oncology, LLC*
*An Affiliate of HealthONE Presbyterian/St. Luke’s Medical Center
1601 East 19th Avenue, Suite 6600
Denver, Colorado 80218
Phone: 303-832-2344
www.cancercare4kids.com


EDUCATION
 
1989                        University of Colorado, Boulder , CO
                               Bachelor of Arts in Environmental,
                               Population, and Organismic Biology

1994                        University of Colorado School of
                               Medicine, Denver, CO
                               Doctor of Medicine with Honors

06/1994 - 06/1997    University of Colorado Health Sciences
                               Center 
                               Pediatric Residency

07/1997 - 04/2001    University of Colorado Health Sciences
                               Center, Denver, CO
                               Pediatric Hematology-Oncology & Bone
                               Marrow Transplant Fellowship


WORK HISTORY

Staff pediatric hematologist-oncologist
Childhood Hematology Oncology Associates
1601 E. 19th Avenue, Suite 5100
Denver, Colorado 80218
07/01/2001 – 11/30/2005


LICENSURE & CERTIFICATION LICENSURE

State of Colorado (#35704)
Drug Enforcement Agency (#BZ5763506)


BOARD CERTIFICATION

National Board of Medical Examiners, 1995

American Board of Pediatrics, 1997; recertification, 2004

American Board of Pediatrics, SubBoard of Pediatric Hematology-Oncology, 2002


PROFESSIONAL ACTIVITIES ORGANIZATIONS

American Medical Association, 1994

American Academy of Pediatrics, 1997

American Society of Pediatric Hematology/Oncology, 2000

American Society of Clinical Oncology, 2000

The Denver Clinic for Extremities at Risk, 2000 - present


HONORS AND AWARDS

1994: Richard C. Hardin Award, Outstanding medical student as voted by peers

1996: Gold Apple Teaching Award, Outstanding resident teacher as voted by medical students

1997: Bruce M. Garber Award, Outstanding resident in class who most embraces pediatric ideal and standards of patient care

1998: Fellow Teacher of the Year Award, Denver Children’s Hospital

1998: News 4 Hometown Hero Award

2004, 2005, 2006: Strathmore’s Who’s Who

2004, 2005, 2006: 5280 Magazine Denver’s Top Physicians


TEACHING

1997-98: Didactic presentations at Tumor Board, a multidisciplinary group

1999: Nursing Core Teaching Series “Basic Immunology”

1997-00: Twenty didactic presentations to the Division of Pediatric Hematology-Oncology, Denver Children’s Hospital

2001-05: Continuing Medical Education for physicians; various topics in pediatric hematology-oncology


CLINICAL TRIAL

2000 Co-principal Investigator, University of Colorado and Bonfils Blood Center A Phase II Multicenter Study of Granulocyte Colon Stimulating Factory (G-CSF) Dexamethasone Mobilized Granulocyte Transfusions for Treatment of Serious Fungal and Bacterial Infections in Neutropenic Patients After Chemotherapy for Hematopoietic Transplantation.


PUBLICATIONS

1. Zimbelman J, Hays T, Nuss R. Priapism as a presentation of protein C deficiency and the factor V Leiden mutation (abstract). J Pediatr Hem Oncol. 1998;20(5).

2. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared to beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18:1096-100.

3. Zimbelman J, Silliman CC, Ambruso DR. Transfusion-related acute lung injury and granulocytes from stored packed RBCs. Transfusion. 2000;40:614-5.

4. Zimbelman J, Lefkowitz J, Schaeffer C, Hays T, et al. Unusual complications of warfarin therapy: skin necrosis and priapism. J Pediatr. 2000;137:266-8.

5. Zimbelman J, Thurman G, Leavey PJ, Ellison MC, Ambruso DR. In vivo treatment with granulocyte-colony stimulating factor does not delay apoptosis in human neutrophils by upregulating the vacuolar proton ATPase. J Investig Med 2002;50:33-7.


PRESENTATIONS

1. “FAQS” about Flesh-Eating Streptococci. Pediatric Grand Rounds, University of Colorado School of Medicine, Denver CO, January 1998.

2. Clindamycin Therapy for Invasive Group A Beta Hemolytic Streptococcus Infection. Annual Meeting of the Society for Pediatric Research, New Orleans LA, May 1-5, 1998.

3. Neutrophil Apoptosis, G-CSF and the Role of the v-ATPase. Division of Pediatric Hematology-Oncology Research Conference,  April 1998.

4. Neutrophil Apoptosis, G-CSF and the Role of the v-ATPase. Division of Pediatric Hematology-Oncology Research Conference, November 1999.

5. In Vivo Treatment with Granulocyte-Colony Stimulating Factor Does Not Delay Apoptosis in Human Neutrophils by Upregulating the Vacuolar Proton ATPase [poster]. Conference of the Federation of American Societies of Experimental Biology, San Diego CA, April 15-18, 2000.

6. Requirement for GTP in a Phosphorylation-Dependent System of Oxidase Activation [poster]. Annual Meeting of the American Society of Hematology, San Francisco CA, December 2-3, 2000.

7. Low White Count Positivity and the Use of Cytogenetic Analysis in Diagnosing CNS Relapse in Standard Risk ALL [poster]. Annual Meeting of The American Society of Pediatric Hematology-Oncology, Baltimore, MD, April 26-29, 2001.